LD-2 disclosure · 2nd Quarter - Termination
C.R. BARD INC.
Client
- Name
- C.R. BARD INC.
- Description
- Medical Device Manufacturer
- Location
- New Jersey · United States of America
Registrant
- Description
- Government affairs and public policy consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesTrade (domestic/foreign)
H.R. 2146, the "Trade Preferences Extension Act." Policy issues relating to the Trans-Pacific Partnership trade agreement.
LobbyistsCHRIS JONES · ADAM HIGGINS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
H.R. 160, the Protect Medical Innovation Act. S.149, the Medical Device Access and Innovation Protection Act. H.R. 880, the American Research and Competitiveness Act.
LobbyistsCHRIS JONES · ADAM HIGGINS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry. H.R. 1078, the "Food and Drug Administration Safety Over Sequestration Act." H.R. 160, the"Protect Medical Innovation Act. S. 149, the "Medical Device Access and Innovation Protection Act." S. 1077, the "Advancing Breakthrough Devices for Patients Act." S. 1622, the "FDA Device Accountability Act." S. 2737, the "Improving Medical Device Innovation Act." Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program. Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
